Anderson G P, White H L, Fennessy M R
Department of Pharmacology, University of Melbourne, Parkville, Victoria, Australia.
Agents Actions. 1988 Jun;24(1-2):1-7. doi: 10.1007/BF01968073.
In anaesthetized guinea-pigs pretreated with propranolol (1 mg/kg, i.v.), platelet activating factor (Paf, 0.02 micrograms/kg, i.v.) caused an acute increase in airways response to histamine (0.5-3.0 micrograms/kg, i.v.) measured as intratracheal pressure. Treatment with the cyclooxygenase inhibitors, aspirin (10 mg/kg, i.v.) or indomethacin (5 mg/kg, i.v.), enhanced the magnitude and duration of this effect but a combined lipoxygenase/cyclooxygenase inhibitor, BW 755C (20 mg/kg, i.v.), prevented the increase in responsiveness. In aspirin treated animals, a putative lipoxygenase inhibitor NDGA (10 mg/kg, i.v.). or atropine methyl nitrate (1 mg/kg, i.v.) or bilateral vagotomy reduced the magnitude of Paf-induced increased histamine responses but did not prevent the effect. Bronchoconstriction induced by Paf was variably influenced by the drug treatments. These data suggest that Paf causes an acute increase in airways responsiveness to histamine in the guinea-pig through a mechanism that may, in part, be dependant on the release of lipoxygenase metabolites.
在用普萘洛尔(1毫克/千克,静脉注射)预处理的麻醉豚鼠中,血小板活化因子(PAF,0.02微克/千克,静脉注射)导致气道对组胺(0.5 - 3.0微克/千克,静脉注射)的反应急性增加,以气管内压力来衡量。用环氧化酶抑制剂阿司匹林(10毫克/千克,静脉注射)或吲哚美辛(5毫克/千克,静脉注射)治疗,增强了这种效应的幅度和持续时间,但一种脂氧合酶/环氧化酶联合抑制剂BW 755C(20毫克/千克,静脉注射)可防止反应性增加。在阿司匹林治疗的动物中,一种假定的脂氧合酶抑制剂NDGA(10毫克/千克,静脉注射)、硝酸甲基阿托品(1毫克/千克,静脉注射)或双侧迷走神经切断术可降低PAF诱导的组胺反应增加的幅度,但不能阻止这种效应。PAF诱导的支气管收缩受到药物治疗的不同影响。这些数据表明,PAF通过一种可能部分依赖于脂氧合酶代谢产物释放的机制,导致豚鼠气道对组胺的反应性急性增加。